Curtis J. Henrich, Ph.D.

Curtis J. Henrich, Ph.D.

  • Center for Cancer Research
  • National Cancer Institute
Molecular Targets Program


For questions about the Assay Development and Screening Section, please contact Dr. Brice Wilson, Acting Head.

Areas of Expertise

Bioassay Development
High-throughput Screening
Natural Products Isolation


Selected Publications

High-throughput screening for identification of inhibitors of EpCAM-dependent growth of hepatocellular carcinoma cells

Henrich CJ, Budhu A, Yu Z, Evans JR, Goncharova EI, Ransom TT, Wang XW, McMahon JB.
Chem Biol Drug Des. 82: 131-9, 2013. [ Journal Article ]

Isobutylhydroxyamides from the pericarp of Nepalese Zanthoxylum armatum inhibit NF1-defective tumor cell line growth

Devkota KP, Wilson J, Henrich CJ, McMahon JB, Reilly KM, Beutler JA.
J. Nat. Prod.. 76: 59-63, 2013. [ Journal Article ]

Matching the power of high throughput screening to the chemical diversity of natural products

Henrich CJ, Beutler JA.
Nat Prod Rep. 30: 1284-98, 2013. [ Journal Article ]

Characterization of pomiferin triacetate as a novel mTOR and translation inhibitor

Bajer MM, Kunze MM, Blees JS, Bokesch HR, Chen H, Brauß TF, Dong Z, Gustafson KR, Biondi RM, Henrich CJ, McMahon JB, Colburn NH, Schmid T, Brüne B.
Biochem. Pharmacol.. 88: 313-21, 2014. [ Journal Article ]

Compounds from Simarouba berteroana which inhibit proliferation of NF1-defective cancer cells

Devkota KP, Wilson JA, Henrich CJ, McMahon JB, Reilly KM, Beutler JA.
Phytochem Lett. 7: 42-45, 2014. [ Journal Article ]


Postdoctoral Fellow (CRTA)
Mohammadnabi Asmani, Ph.D.
Nirmala Sharma
Research Associate (Leidos)
Emily Smith, M.S.
Postbaccalaureate Fellow (CRTA)
Nicolle Viloria
Senior Research Technician (Leidos)
Antony Wamiru
Biological Lab Technician
Jennifer A. Wilson